As research continues to support the use of psychedelics and plant base medicine to treat a range of mental health and behavioral disorders, the success of this growing movement largely depends on the ability to secure insurance coverage.

​

A major challenge for psychedelic medicinal businesses is finding the right coverages or any coverage at all, leaving you exposed to a wide spectrum of risks. Complicating matters, each state has their own set of laws, which are rapidly evolving.

 

R&A PSYINS offers licensed therapists and clinicians, Ketamine clinics, drug and product developers, mushroom cultivators, early and late-stage research and development, wellness retreats, as well as private equity and investors in the psychedelic sector with access to specialty lines of insurance products.